Treatment of Bacterial Conjunctivitis
The first-line treatment for bacterial conjunctivitis is topical antibiotic therapy, with broad-spectrum options including ciprofloxacin, polymyxin B-bacitracin, trimethoprim-polymyxin B, gentamicin, tetracycline, or ofloxacin for a standard course of 5-7 days. 1
Clinical Presentation and Diagnosis
Bacterial conjunctivitis typically presents with:
- Purulent or mucopurulent discharge
- Matting of eyelids (especially upon waking)
- Conjunctival injection (redness)
- Mild discomfort or foreign body sensation
- Absence of significant pain or vision loss 1
Common causative organisms include:
- Haemophilus influenzae
- Streptococcus pneumoniae
- Staphylococcus aureus
- Staphylococcus epidermidis
- Moraxella species 1, 2
Treatment Algorithm
Standard Cases
First-line treatment options:
- Topical gentamicin
- Topical tetracycline
- Topical ofloxacin
- Ciprofloxacin
- Polymyxin B-bacitracin
- Trimethoprim-polymyxin B 1
Newer fluoroquinolone option:
Duration of treatment:
- Standard course: 5-7 days
- Continue until:
- Resolution of discharge
- No more matting of eyelids in the morning
- Reduction in conjunctival injection 1
Special Cases
Gonococcal conjunctivitis:
- BOTH systemic and topical therapy required
- Systemic: Ceftriaxone (single dose)
- Plus topical antibiotic therapy 1
Chlamydial conjunctivitis:
- Systemic therapy with one of:
- Azithromycin (1g orally, single dose) OR
- Doxycycline (100mg orally twice daily for 7 days) OR
- Levofloxacin (500mg orally once daily for 7 days) 1
- Systemic therapy with one of:
Neonatal conjunctivitis:
- Requires prompt evaluation and treatment based on timing:
- 1-7 days after birth: Consider gonococcal infection
- 5-19 days: Consider chlamydial infection
- First week: Common bacterial infection (S. aureus, Enterococcus, Klebsiella, E. coli) 1
- Requires prompt evaluation and treatment based on timing:
Considerations for Antibiotic Selection
- Fluoroquinolones like gatifloxacin and moxifloxacin offer broad-spectrum coverage and excellent tissue penetration 4
- Gatifloxacin 0.5% is FDA-approved for bacterial conjunctivitis caused by:
- S. aureus, S. epidermidis, S. pneumoniae (gram-positive)
- H. influenzae (gram-negative) 3
- Increasing resistance to fluoroquinolones has been reported, particularly in MRSA isolates 1
- Delayed antibiotic prescribing may be considered for mild cases 1, 5
Prevention and Infection Control
- Frequent handwashing
- Avoid sharing towels and pillowcases
- Proper disinfection of surfaces
- Patients with bacterial conjunctivitis can typically return to work or school after 24 hours of antibiotic treatment 1
When to Refer to Ophthalmology
Refer if:
- No response to therapy after 3-4 days
- Moderate to severe pain
- Decreased vision
- Corneal involvement
- Conjunctival scarring
- Recurrent episodes
- History of herpes simplex virus eye disease
- Immunocompromised patients 1, 5
Important Caveats
- Indiscriminate use of antibiotics should be avoided as mild bacterial conjunctivitis is often self-limiting 1, 6
- Contact lens wearers should discontinue lens wear during treatment 3
- Patients should be advised not to wear contact lenses if they have signs and symptoms of bacterial conjunctivitis 3
- Prolonged use of antibiotics may result in overgrowth of nonsusceptible organisms, including fungi 3